FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups

A senior man getting covid 19 vaccine in hospital. Vaccination, inoculation and health care.

Key Takeaways

  • Federal regulators will only approve COVID-19 boosters for seniors and high-risk groups

  • Officials want more data before recommending shots for healthy individuals

  • More than 100 million Americans would still qualify under the new plan

Originally published on healthday.com, part of the BLOX Digital Content Exchange.